Options For Community-Based Services For Behavioral Health

Executive Briefing | November 18, 2017
Athena Mandros We’ve written a lot about the cost of untreated addiction treatment disorders and serious mental illness and its impact on communities – see Opioid-Related Hospital Stays Increase 121.6% In Small Metro Areas, Cleveland-Area Hospitals Put 79% Of Behavioral Health Emergency Visits On Wait List For Admission, The Ethics Of The Medical Costs Of Opioid Addiction, and Opioid Addiction – The Crisis, The Impact & The Responses. In certain communities, access to treatment is exacerbated due to geography, limited resources, and state choice to not expand Medicaid. Additionally, while the federal government has made some commitment to treating addiction via the 21st Century Cures Act and the Comprehensive Addiction and Recovery Act (CARA), these initiatives are not enough to solve the problems in all communities...

State-By-State Analysis Of Medicaid MCO Requirements For Provider Alternative Payment Models: The 2017 Update

Market Intell Report | October 31 2017
Alternative payment methodologies (APMs) is an umbrella term used to describe payment models that focus on quality, cost of care, or both, rather than utilizing pay-for-volume or fee-for-service payment models. APM are used across all payers—Medicare, Medicaid, and commercial—in different ways and at different levels. This report updates our 2016 report and looks at the use of APMs in...

FDA Approves Abilify MyCite® (Aripiprazole Tablets With Sensor), A Pill With Digital Sensor To Track Oral Antipsychotic Ingestion

News Report | November 19 2017
On November 13, 2017, the U.S. Food and Drug Administration (FDA) approved Abilify MyCite (aripiprazole tablets with sensor), the first drug in the United States with a digital ingestion tracking system. Abilify MyCite is the tablet form of the antipsychotic aripiprazole manufactured with an embedded ingestible sensor. The sensor records that the medication was taken, and communicates that information...

More Market Intelligence Headlines


Most Popular

Help

Close

Support Request

Need help now?

Call our toll-free phone number 877-350-6463